36C77019Q0450-005.pdf

Chapter VI: Other Than Full and Open Competition (OFOC) SOP Attachment 1: Justification for Limiting Sources $3.5K up to $150K

OFOC SOP Revision 05 Page 1 of 2 Original Date: 03/22/11 Revision 05 Date: 05/02/2016

FAR 8 - JUSTIFICATION FOR LIMITING SOURCES <$150K

Acquisition Plan Action ID: 763-19-3-021-0789

1. Agency and Contracting Activity: Department of Veterans Affairs, VISN 15,Lancaster TX

CMOP

2. Description of Action:

Nature: xNew Requirement Follow-on Order Mod to Existing Order Number Insert task/delivery order no.

3. Description of Supplies or Services:

A. SET,INFUSION MINIMED #MMT-378

B. RESERVOIR,MINIMED #MMT-332A

4. Authority: Brand specific med-surg items are requested by Doctors and Physicians at the

VAMC served by Dallas VA CMOP

ORDER AGAINST FSS: Authority of the Multiple Award Schedule Program, Title III of the Federal Property and Administrative Services Act of 1949 (41 USC 251, et seq.); Title 40 USC 501, Services for Executive Agencies; and Section 803 of the National Defense Authorization Act of 2002 (PL 107-107) and implemented by FAR 8.405-6. Mark the applicable exception:

An urgent and compelling need exists, and following the procedures would result in unacceptable delays(FAR 8.405-6(a)(1)(i)(A);

Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized;

(FAR 8.405-6(a)(1)(i)(B)) or

In the interest of economy and efficiency, the new work is a logical follow-on to an original Federal Supply Schedule order and the original order was placed in accordance with the applicable Federal Supply Schedule ordering procedures. The original order was not previously issued under sole-source or limited-sources procedures. (FAR 8.405-6(a)(1)(i)(C)

5. Rational/explanation to support cited authority:

Within the VHA brand name drugs and med surge items may be prescribed by physicians when in their clinical judgment the brand name drug will provide a better therapeutic outcome for patients. Brand name drugs are requested when there is a clinical requirement for the drug . In this case, the brand specific name is requested on the list above.

Chapter VI: Other Than Full and Open Competition (OFOC) SOP Attachment 1: Justification for Limiting Sources $3.5K up to $150K

OFOC SOP Revision 05 Page 2 of 2 Original Date: 03/22/11 Revision 05 Date: 05/02/2016

6. BRAND NAME ONLY: This buy is estimated to exceed $25,000 and this documentation will be posted along with the RFQ on e-Buy, as required by FAR 8.405-6(b)(3).

7. Note that this determination satisfies the requirements of FAR 8.405-6. The requirement to prepare a written justification IAW FAR 6.303 does not apply to Federal Supply Schedules.

Tronny Mccoggle Inventory Management Contracting Officer/Designee